Page Content
to Navigation
2016
- Henschke C, Panteli D, Perleth M, Busse R (2016): Taxonomy of Medical Devices in the Logic of Health Technology Assessment
- Panteli D, Kreis J, Busse R (2016): Considering Equity in Health Technology Assessment: An Exploratory Analysis of Agency Practices
- Fuchs S, Olberg B, Panteli D, Perleth M, Busse R (2017): HTA of medical devices: Challenges and ideas for the future from a European perspective. Health Policy.
- Fuchs S, Olberg B, Panteli D, Busse R (2016): Health Technology Assessment of medical devices in Europe: processes, methods and practices.
2015
- Henschke C, Panteli D, Perleth M, Busse R (2015): A taxonomy of medical devices in the logic of HTA.
- Panteli D, Kreis J, Busse R (2015): Considering equity in HTA: an exploratory analysis of agency practices
- Panteli D, Wittenbecher F, Busse R (2015): Medizinischer Zusatznutzen von Hämodiafiltration gegenüber Hämodialyse bezüglich Mortalität und Lebensqualität
2014
- Kreis J, Panteli D, Busse R (2014): How health technology assessment agencies address the issue of unpublished data. Int J Technol Assess Health Care 30(1): 34-43
- Perleth M, Busse R, Gerhardus A, Gibis B, Lühmann D, Zentner A (Hrsg.) (2014): Health Technology Assessment – Konzepte, Methoden, Praxis für Wissenschaft und Entscheidungsfindung. 2. Aufl. Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft
2007
- Angermayr L, Velasco Garrido M, Busse R (2007): Ventricular assist devices for heart failure. GMS Health Technol Assess 3: Doc10
- Heintze C, Velasco Garrido M, Kroeger A (2007): What do community-based dengue control programmes achieve? A systematic review of published evaluations. Transactions of the Royal Society of Tropical Medicine and Hygiene (2007) 101, 317—325
2003
- Gernreich NC, Gerhardus A, Velasco-Garrido M (2003): Knochen- und Knochenersatzmaterialien zur parodontalen Regeneration und zum Knochenaufbau für Implantate (Health Technology Assessment, Bd. 32). Sankt Augustin: Asgard-Verlag
- Velasco-Garrido M, Busse R (2003): Whose "wish bias"? Ann Oncol 2003;14:1154
- Velasco-Garrido M, Busse R, Hishashage A (2003): Are disease management programmes (DMPs) effective in improving quality of care for people with chronic conditions? Copenhagen: WHO Regional Office for Europe's Health Evidence Network (HEN)
2001
- Perleth M, Busse R (2001): Health Technology Assessment of oral anticoagulation following heart valve replacement. Eur Heart J Suppl 3: Q60-64
- Perleth M, Busse R, Gibis B, Brand A (2001): Evaluation of preventive technologies in Germany – Case studies on mammography, prostate cancer screening and fetal ultrasound. Int J Technology Assessment Health Care 17(3): 329-337
- Perleth M, Jakubowski E, Busse R (2001): What is "Best Practice" in Health Care? State of the Art and Perspectives in Improving the Effectiveness and Efficiency of the European Health Care Systems. Health Policy 56(3): 235-250
1999
- Busse R, Hoopmann M, Schwartz FW (1999): Which factors determine the use of diagnostic imaging technologies for gastrointestinal complaints in general medical practice? Int J Technology Assessment Health Care 15(4): 629-637
- Bitzer E, Busse R, Kohlmann T, Lühmann D, Perleth M (1999): Health Technology Assessment im internationalen Kontext: Wo steht Deutschland? Z ärztliche Fortbildung Qualitätssicherung 93(1): 33-38
- European Commission, Directorate-General for Employment, Industrial Relations and Social Affairs (ed.) (1999): “Best practice“: State of the art and perspectives in the EU for improving the effectiveness and efficiency of European health systems. Writ
- Krauth C, Busse R, Smaczny C, Ullrich G, Wagner TOF, Weber J, Welte T (1999): Kostenvergleichsanalyse der stationären und ambulanten Intervalltherapie bei erwachsenen Mukoviszidose-Patienten: Ergebnisse einer prospektiven kontrollierten Studie. Med Klini
- Perleth M, Busse R, Schwartz FW (1999): Regulation of health-related technologies in Germany. Health Policy 46(2): 105-126
- Perleth M, Mannebach H, Busse R, Gleichmann U, Schwartz FW (1999): Cardiac catheterisation in Germany: diffusion and utilization from 1984 to 1996. Int J Technology Assessment Health Care 15(4): 756-766